How to buy West Pharmaceutical Services (WST) shares in Australia
Learn how to easily invest in West Pharmaceutical Services shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
West Pharmaceutical Services Inc (WST) is a leading medical instruments & supplies business with stocks listed in the US. It opened the day at US$374.47 after a previous close of US$373.11. During the day the price has varied from a low of USD371.55 to a high of USD375.19. The latest price was USD374.19 (25 minute delay). West Pharmaceutical Services is listed on the NYSE. All prices are listed in US Dollars.
How to buy shares in West Pharmaceutical Services
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for West Pharmaceutical Services. Find the share by name or ticker symbol: WST. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until West Pharmaceutical Services reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$373.11, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of West Pharmaceutical Services, depending on your broker.
- Check in on your investment. Congratulations, you own a part of West Pharmaceutical Services. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- West Pharmaceutical Services key stats
- Compare share trading platforms
- Is West Pharmaceutical Services stock a buy or sell?
- West Pharmaceutical Services performance over time
- Are West Pharmaceutical Services shares over-valued?
- West Pharmaceutical Services's financials
- How volatile are West Pharmaceutical Services shares?
- Does West Pharmaceutical Services pay a dividend?
- Have West Pharmaceutical Services shares ever split?
- Other common questions
West Pharmaceutical Services stock price (NYSE:WST)Use our graph to track the performance of WST stocks over time.
West Pharmaceutical Services shares at a glance
|52-week range||US$253.492 - US$475.143|
|50-day moving average||US$435.5932|
|200-day moving average||US$392.7062|
|Dividend yield||US$0.68 (0.18%)|
|Earnings per share (TTM)||US$8.0675|
Where to buy West Pharmaceutical Services stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy West Pharmaceutical Services stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
West Pharmaceutical Services price performance over time
|1 week (2022-01-10)||-4.68%|
|1 month (2021-12-17)||-16.81%|
|3 months (2021-10-15)||-7.56%|
|6 months (2021-07-17)||0.29%|
|1 year (2021-01-15)||24.98%|
|2 years (2020-01-17)||137.45%|
|3 years (2019-01-17)||258.90%|
|5 years (2017-01-17)||344.09%|
Stocks similar to West Pharmaceutical Services
Is West Pharmaceutical Services under- or over-valued?
Valuing West Pharmaceutical Services stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of West Pharmaceutical Services's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
West Pharmaceutical Services's P/E ratio
West Pharmaceutical Services's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 83x. In other words, West Pharmaceutical Services shares trade at around 83x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
West Pharmaceutical Services's PEG ratio
West Pharmaceutical Services's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.2976. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into West Pharmaceutical Services's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
West Pharmaceutical Services's EBITDA
West Pharmaceutical Services's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$808.1 million (£0.0 million).
The EBITDA is a measure of a West Pharmaceutical Services's overall financial performance and is widely used to measure a its profitability.
West Pharmaceutical Services financials
|Revenue TTM||US$2.7 billion|
|Operating margin TTM||25.8%|
|Gross profit TTM||US$767.8 million|
|Return on assets TTM||15.1%|
|Return on equity TTM||3116.9%|
|Market capitalisation||US$28.9 billion|
TTM: trailing 12 months
West Pharmaceutical Services share dividends
Dividend payout ratio: 8.85% of net profits
Recently West Pharmaceutical Services has paid out, on average, around 8.85% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.18% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), West Pharmaceutical Services shareholders could enjoy a 0.18% return on their shares, in the form of dividend payments. In West Pharmaceutical Services's case, that would currently equate to about $0.68 per share.
While West Pharmaceutical Services's payout ratio might seem low, this can signify that West Pharmaceutical Services is investing more in its future growth.
West Pharmaceutical Services's most recent dividend payout was on 1 February 2022. The latest dividend was paid out to all shareholders who bought their shares by 17 January 2022 (the "ex-dividend date").
Have West Pharmaceutical Services's shares ever split?
West Pharmaceutical Services's shares were split on a 2:1 basis on 26 September 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your West Pharmaceutical Services shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for West Pharmaceutical Services shares which in turn could have impacted West Pharmaceutical Services's share price.
West Pharmaceutical Services share price volatility
Over the last 12 months, West Pharmaceutical Services's shares have ranged in value from as little as US$253.492 up to US$475.143. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while West Pharmaceutical Services's is 0.9696. This would suggest that West Pharmaceutical Services's shares are less volatile than average (for this exchange).
West Pharmaceutical Services overview
West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
West Pharmaceutical Services in the news
Declining Stock and Solid Fundamentals: Is The Market Wrong About West Pharmaceutical Services, Inc. (NYSE:WST)?
McLean Asset Management Corp Buys Avantis U.S. ...
Ex-Div Reminder for West Pharmaceutical Services
Frequently asked questions
More guides on Finder
Interview: RAQ founder talks Abbie Chatfield swim collection
RAQ Apparel founder Sophia Argyropoulos chats the inspo for Abbie Chatfield swimwear collab and the secret to finding the perfect bikini.
7 ways to elevate your home movie experience [SPONSORED] Turn your low-key movie nights into a main attraction that can keep everyone entertained.
American Express Qantas Corporate Gold Card
With a 100,000 bonus Membership Rewards offer and complimentary Qantas Business Rewards membership, is this the right card for your business?
How to watch Liverpool vs Arsenal Carabao Cup live and free in Australia
Liverpool and Arsenal battle for a place in the League Cup final.
Rapid antigen tests: When will RAT stock be available? [UPDATED]
Rapid antigen tests are proving extremely hard to find, but there are options if you can be patient trying to find a RAT.
New on Netflix, Prime Video, Disney Plus, Stan, Foxtel, BINGE and more in January 2022
You can easily elevate your binge-watching game in the New Year.
Where to watch DC series Peacemaker online in Australia
He believes in peace at any cost – no matter how many people he has to kill to get it.
How to watch Melbourne Renegades vs Melbourne Stars BBL live and match preview
Both Melbourne teams are fighting for their seasons as we embark on derby number 2
10 beauty trends that’ll pop off in 2022
From clean beauty to bedazzled everything, these are the makeup looks will take over 2022 and the products you need to pull them off.
Compare rapid antigen test brands: How do they stack up?
Not all tests are created equal here are the different brands compared.
Ask an Expert